Stifel Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $16
Analysts' Opinions Are Mixed on These Healthcare Stocks: Pulmonx (LUNG) and Bristol-Myers Squibb (BMY)
Wells Fargo Maintains Pulmonx(LUNG.US) With Hold Rating, Cuts Target Price to $6
Pulmonx Corporation (NASDAQ:LUNG) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Pulmonx | 10-Q: Q1 2025 Earnings Report
Catalyst Watch: Powell Presser, AMD Earnings, IBM Event, and Lions Gate Splits in Two
Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference
Pulmonx Is Maintained at Buy by Canaccord Genuity
Pulmonx Price Target Cut to $15.00/Share From $16.00 by Canaccord Genuity
12 Health Care Stocks Moving In Thursday's Intraday Session
Piper Sandler Reiterates Overweight on Pulmonx, Lowers Price Target to $9
Express News | D. Boral Capital Maintains Buy on Pulmonx, Maintains $17 Price Target
Pulmonx Analyst Ratings
Earnings Call Summary | Pulmonx(LUNG.US) Q1 2025 Earnings Conference
Pulmonx Projects 20% Long-term Growth Amid Expanded Initiatives and $12B Market Opportunity
Pulmonx Backs 2025 Rev $96M-$98M >LUNG
Pulmonx: Reaffirmed Guidance Doesn't Reflect Potential Impact From Future Tariffs or Trade Policy Changes, or Their Effects on the Global Macroeconomic Environment >LUNG
Express News | Pulmonx Affirms FY2025 Sales Guidance of $96.00M-$98.00M Vs $96.91M Est
Pulmonx GAAP EPS of -$0.36 Beats by $0.04, Revenue of $22.5M Beats by $0.47M
Pulmonx | 8-K: Pulmonx Reports First Quarter 2025 Financial Results